Posted by Adam aam on September 26 2026 at 01:51 PM
public
Rockville, MD., September 26, 2026 — The Lipid Metabolism Modulators Market is projected to grow from USD 39.17 billion in 2026 to USD 66.18 billion by 2036, expanding at a 5.4% CAGR, according t...
Posted by Surbhi on July 14 2026 at 07:01 PM
public
Sclerostin monoclonal antibody therapy — the Wnt signaling pathway inhibition promoting osteoblast-mediated bone formation representing the fastest-growing anabolic segment in the global bone and...
